Skip to main content
TipRanks
Go Ultimate75% OFF
Gamgee logo

Gamgee: Valuation, Funding & Investors

Gamgee is an Australian biotechnology startup developing AI-powered personalized mRNA cancer vaccines for dogs. The company uses a data-driven platform that integrates tumor sequencing, AI protein modeling, and automated vaccine design to deliver rapid, targeted immunotherapies and aims to industrialize production through a SaaS-based production line.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$4M
Total Funding Rounds
1
Latest Funding Amount
$4M
Latest Funding Round
Seed Round

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Aug 24, 2026Seed Round$4.00M―

Investors

Investor NameFunding Round
Founders FundSeed Round
Y CombinatorSeed Round
Celine HaliouaSeed Round
Arash FerdowsiSeed Round

Similar Companies

A snapshot of private companies similar to Gamgee, helping you discover and navigate related company profiles.

Related News and Analysis